Oral contraception and the recognised gynaecological indications for such oestrogen-progestogen combinations. The decision to prescribe Microgynon 30 ED should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Microgynon 30 ED compares with other combined hormonal contraceptives (CHCs) (see sections 4.3 and 4.4).
Oral contraception and the recognised gynaecological indications for such oestrogen-progestogen combinations. The decision to prescribe Microgynon 30 should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Microgynon 30 compares with other combined hormonal contraceptives (CHCs) (see sections 4.3 and 4.4).
Emerging neuromodulation devices show promise for expanding acute treatment options. Over the past few years, there has been a growth in research investigating the efficacy and safety of non-invasive neuromodulation, which delivers electrical or magnetic stimulation to nerves or neural tissue, for the management of acute attacks of migraine
Background: Asthma exacerbations are frequent in patients with severe disease. This report describes results from two retrospective cohort studies describing exacerbation frequency and risk, emergency department (ED)/hospital re-admissions, and asthma-related costs by asthma severity in the US and UK.
Oral contraception and the recognised gynaecological indications for such oestrogen progestogen combinations. The decision to prescribe Femodene ED should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Femodene ED compares with other combined hormonal contraceptives (CHCs) (see sections 4.3 and 4.4).
When a patient arrives to an emergency department and is found to have an elevated potassium level in the blood, there is no one standardized treatment, therefore it is not known if one treatment is superior to other.